Avenue Therapeutics, Inc. (ATXI)
NASDAQ: ATXI · Real-Time Price · USD
1.850
0.00 (0.00%)
At close: Jan 21, 2025, 4:00 PM
1.930
+0.080 (4.32%)
After-hours: Jan 21, 2025, 7:47 PM EST
Avenue Therapeutics Statistics
Total Valuation
ATXI has a market cap or net worth of $3.54 million. The enterprise value is $939,521.
| Market Cap | 3.54M |
| Enterprise Value | 939,521 |
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ATXI has 1.91 million shares outstanding. The number of shares has increased by 933.39% in one year.
| Current Share Class | 1.91M |
| Shares Outstanding | 1.91M |
| Shares Change (YoY) | +933.39% |
| Shares Change (QoQ) | +43.16% |
| Owned by Insiders (%) | 1.18% |
| Owned by Institutions (%) | 4.19% |
| Float | 1.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.70
| Current Ratio | 2.70 |
| Quick Ratio | 2.67 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -471.94% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$6.09M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -82.39% in the last 52 weeks. The beta is -0.27, so ATXI's price volatility has been lower than the market average.
| Beta (5Y) | -0.27 |
| 52-Week Price Change | -82.39% |
| 50-Day Moving Average | 1.92 |
| 200-Day Moving Average | 3.34 |
| Relative Strength Index (RSI) | 47.67 |
| Average Volume (20 Days) | 68,914 |
Short Selling Information
The latest short interest is 22,479, so 1.18% of the outstanding shares have been sold short.
| Short Interest | 22,479 |
| Short Previous Month | 35,071 |
| Short % of Shares Out | 1.18% |
| Short % of Float | 1.52% |
| Short Ratio (days to cover) | 0.73 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.81M |
| Pretax Income | -5.87M |
| Net Income | -18.28M |
| EBITDA | n/a |
| EBIT | -11.81M |
| Earnings Per Share (EPS) | -$20.51 |
Balance Sheet
| Cash & Cash Equivalents | 2.60M |
| Total Debt | n/a |
| Net Cash | 2.60M |
| Net Cash Per Share | $1.36 |
| Equity (Book Value) | 1.65M |
| Book Value Per Share | 1.63 |
| Working Capital | 1.65M |
Cash Flow
| Operating Cash Flow | -10.59M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.59M |
| FCF Per Share | -$5.54 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATXI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -933.39% |
| Shareholder Yield | -933.39% |
| Earnings Yield | -516.84% |
| FCF Yield | -299.33% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.0133333:1.
| Last Split Date | Apr 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0133333:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |